Vanda Pharmaceuticals (VNDA) Earnings Analysis
Vanda Pharmaceuticals (VNDA) next reports earnings on 2026-07-30, consensus EPS -0.5825 USD. Last quarter (2025-10-29) it missed with EPS -0.38 USD vs -0.31 USD est (-22.6%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E -1.32.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does VNDA next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | -0.5825 USD |
| Revenue estimate | 0.06B |
VNDA earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-10-29 | -0.38 USD | -0.31 USD | -22.6% | Miss |
| 2025-07-31 | -0.46 USD | -0.34 USD | -35.3% | Miss |
| 2025-02-13 | -0.08 USD | -0.14 USD | +42.9% | Beat |
Beat rate: 1/3 (33%) over reported quarters with consensus data.
VNDA valuation and analyst view
| Trailing P/E | -1.32 |
|---|---|
| Trailing EPS | -4.02871 USD |
| Price / book | 1.13 |
| Dividend yield | 0.00% |
| Market cap | 0.33B |
| Analyst consensus | Buy (13 buy / 5 hold / 1 sell) |
| Avg price target | 21 USD |
Related research pages
Frequently asked questions
When is Vanda Pharmaceuticals (VNDA)'s next earnings date?
Vanda Pharmaceuticals is next scheduled to report on 2026-07-30, with a consensus EPS estimate of -0.5825 USD and revenue estimate of 0.06B.
Did VNDA beat earnings last quarter?
In its 2025-10-29 report, VNDA posted EPS of -0.38 USD versus a -0.31 USD estimate — a miss of 22.6%.
What is VNDA's earnings track record?
Over the last 3 reported quarters with consensus data, VNDA beat estimates 1 times (33%).
What is VNDA's current P/E ratio and EPS?
VNDA trades at a trailing P/E of -1.32 on trailing EPS of -4.028709594967586 USD.
What do analysts rate VNDA?
Analyst consensus is "Buy" across 19 ratings (0 strong buy, 13 buy, 5 hold, 1 sell, 0 strong sell). Average 12-month price target: 21 USD.